MedPath

Hair growth trial

Not Applicable
Conditions
Healthy adult
Registration Number
JPRN-UMIN000045196
Lead Sponsor
Yamada Bee Company, Inc.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
27
Inclusion Criteria

Not provided

Exclusion Criteria

[1]Subjects with pathological hair loss such as alopecia areata [2]Subjects with scalp diseases other than hair loss (eg, head eczema, seborrheic eczema, psoriasis, tinea capitis, and other scalp infections) [3]Subject with reduced or abnormal thyroid function [4]Subjects with photosensitivity disorder [5]Subjects receiving "hormone replacement therapy" or taking oral contraceptives within one year [6]Subjects who are pregnant or lactating, or who intend to become pregnant [7]Subject with atopic dermatitis [8]Subjects who habitually apply or take external preparations, oral medicines, supplements, etc. that may affect the condition of the head [9]Subjects with a history of hypersensitivity (allergies) to hair growth agents, hair restorer, cosmetics (shampoo, etc.), or hypersensitivity to other medicines. [10]Subjects who have been treated with radiation therapy to the head or cancer chemotherapy within the last 6 months, or who will be treated within the next 2 months after the end of the study [11]Subjects who regularly use wigs during the study period, subjects who have undergone hair transplantation or hair growth, or subjects who are scheduled during the study period [12]Subjects who have been treated with pharmaceutical hair growth agents (such as finasteride, minoxidil, or carpronium chloride-containing preparations) within the past 6 months [13]Subjects who have used existing hair growth agents and hair restorer within the past 2 months, regardless of whether they are pharmaceutical products or quasi-drugs. [14]Subjects currently using medical medications known to cause trichotillomania or hirsutism (eg, phenytoin for epilepsy) [15]Subjects working for cosmetics companies and pharmaceutical companies [16]Subjects judged to be ineligible for this study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Photo Trichogram (Growth rate, Hair diameter, Anagen hair percentage,Hair number)
Secondary Outcome Measures
NameTimeMethod
Stratum corneum water content of the scalp,Questionnaire survey,Head photography (front side of head, back side of head),Adverse event investigation
© Copyright 2025. All Rights Reserved by MedPath